k8凯发(中国)天生赢家·一触即发

Wuxi Mingci Cardiovascular Hospital is invested and built by the listed company Jiangnan Mould & Plastic Technology Co., Ltd. It is a modern tertiary cardiovascular specialized hospital with international service concept and excellent diagnosis and treatment technology. The hospital covers a construction area of nearly 70000 square meters and a planned total of 450 beds. It is equipped with 6 operating rooms (including 1 hybrid operating room) and 4 catheterization rooms. The first phase of the hospital is planned with 150 open beds.

The introduction of German medical management mode, medical technology and cooperation with excellent domestic medical institutions are the distinctive features of Wuxi Mingci Cardiovascular Hospital. The hospital, together with the internationally renowned Heart and diabetes Center (HDZ) in North Westphalia, Germany and Fuwai Hospital of the Chinese Academy of Medical Sciences, takes cardiovascular disease and diabetes as its specialized direction, bringing international expert selection, sophisticated diagnosis and treatment technology, and more high-end, professional and high-quality medical services to patients.

The hospital has introduced internationally advanced medical equipment, including Siemens 1.5T magnetic resonance imaging, dual source spiral CT, DSA, DR, cardiac ultrasound, Roche fully automatic biochemical immune analyzer, central electrocardiogram monitoring system, Sorin extracorporeal circulation machine, etc. The hospital possesses advanced composite operating rooms, which can provide patients with safe, high-quality, efficient, accurate, and comprehensive diagnosis and treatment services.

Wuxi Mingze Medical Diagnostic Center Co., Ltd. is located at No. 2 Gonghu Avenue, Liangxi District, Wuxi City, Jiangsu Province. Company was founded in 2018. It is a independent  third-party testing institution with six major professional testing capabilities, including clinical laboratory major, clinical microbiology major, clinical chemical testing major, clinical immunology major, clinical cell and molecular heritage major, and exfoliative cytology major.  It has also ventured into cutting-edge fields such as flow cytometry, mass spectrometry, digital PCR, and second-generation sequencing.

In May 2023, the company launched the quality system accreditation work for ISO15189. Currently, it has entered the trial operation stage. All employees of Mingze Diagnostic Center will adhere to the quality goal of "precision and timeliness, service first, lean management, and continuous improvement", unite sincerely, forge ahead, and innovate continuously, striving to become the vanguard and leader of independent medical laboratories in Wuxi.

Wuxi Junbo Stomatological Hospital Co., Ltd. was established in 2016 and is a designated medical insurance unit in Wuxi City. It was founded by medical staff who have been engaged in dental profession in military medical units for a long time and independently choose their own careers. We have a team of excellent physicians and experts with rich clinical experience from public tertiary hospitals and dental specialty hospitals. We have obvious characteristics and advantages in implant dentures, correction of dental deformities, treatment of dental pulp and periapical diseases, preservation and restoration of residual roots and crowns, and denture restoration technology. In addition, we have formed a development direction characterized by CAD/CAM restoration body production, digital design of edentulous jaws and 3D guide printing, and digital orthodontic design in the field of oral digital application.

Wuxi Junbo Stomatological Hospital adheres to the service concept of "patient-centered everything", strictly implements hospital infection management requirements, and provides standardized and orderly diagnosis and treatment operations and disinfection supply. Implementing "one doctor, one patient, one diagnosis, one disinfection" to ensure medical quality, committed to providing professional and caring services for the vast number of oral patients.

Wuxi Mingrun Hospital Management Co., Ltd. was established in December 2017, specializing in the management and standardized chain operation of blood dialysis medical institutions. Since its establishment, the company has been committed to providing high-quality medical services for kidney disease patients. It is a professional kidney disease medical institution that integrates prevention and health care, kidney disease treatment, chronic disease management, and psychological rehabilitation.

The company has an excellent management team and a professional medical team. Adhering to the service concept of "patient-centered", the company strictly follows the SOP standards of the National Health Commission for planning and design, equipped with internationally renowned brand dialysis machines and filters, high-purity dialysis water and other world leading medical equipment and facilities. Using advanced dialysis treatment technology and management models, the company develops personalized dialysis plans for kidney disease patients. At the same time, a new multi-level and all-round health management model is established around kidney disease, effectively reducing social medical costs, improving the patient's diagnosis and treatment experience, and truly realizing the comprehensive recovery of patients in terms of body, mind, society, and spirit.